RGS 0.00% 12.0¢ regeneus ltd

AFR article on regenerative medicine in Japan, page-6

  1. 4,884 Posts.
    lightbulb Created with Sketch. 2
    FYI, here is John Martin's Austrade mission presentation in Japan - RGS has a good story to tell.
    There is a fair bit of news coning up this quarter for Progenza

    (From Slide 22): Anticipated Milestones for next 18 months
    Progenza
    • Advance clinical partnering discussions for Progenza in Japan Ongoing
    • Commence donor procurement and process development for manufacturing for Phase 2 trial in Japan Q2 ’17
    • Report on osteoarthritis STEP trial Q2’17
    • Commence chronic pain preclinical study Q2’17

    http://static.ow.ly/docs/Austrade Mission to Japan April '17_6d5n.pdf
 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.